1. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion

2. Background

3. Case #1: Initial Presentation

4. Case #1: Response to Treatment With Dupilumab

5. Case #1: Response to Treatment With Dupilumab (cont)

6. Case #1: Response to Treatment With Dupilumab (cont)

7. Approach to the Patient With Moderate to Severe AD

8. When to Initiate Systemic Therapy

9. Factors Influencing Selection of a Systemic Therapy

10. Dupilumab in AD: SOLO1 and SOLO2

11. Dupilumab in AD: Long-Term Efficacy

12. Dupilumab Plus TCS in AD: CHRONOS

13. Effect of Dupilumab on Pruritus and QoL

14. Case #2: Initial Presentation

15. Case #2: Response to Treatment With Dupilumab

16. Considerations in Using Dupilumab in Clinical Practice

17. Managing Treatment-Related Adverse Events

18. Looking Ahead: Investigational Agents for AD

19. Conclusions

20. Abbreviations